Discover 374 paid clinical trials in Quebec City, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 374
FeaturedActive & Responsive
Brief Skills for Safer Living (Brief-SfSL)
for
Suicide Prevention, Suicide, Suicide and Self-harm, Depression,
Location: Quebec City, Sherbrooke, Montreal, Fredericton,
Sponsor: Unity Health Toronto
Sex: All
Age: 18+
Code: NCT06571916
Recruiting
Active & Responsive
Lupus Landmark Study: A Prospective Registry and Biorepository
Location: Quebec, Montreal, Boston MA, Worcester MA, Syracuse NY,
Sponsor: Lupus Research Alliance
Sex: All
Age: 18 - 70+
Code: NCT05934149
Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Quebec, Lebanon NH, Ottawa, Boston MA, Torrington CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: Quebec, Montreal, Boston MA, Mineola NY, Toronto,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
for
Cervical Cancer
Location: Quebec, Toronto
Sponsor: University Health Network, Toronto
Sex: Female
Age: 18 - 40
Code: NCT04016389
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Comprehensive Assessment of Neurodegeneration and Dementia
Cranial Nerve Neuromodulation to Improve Arm Function and Brain Plasticity in Stroke
for
Stroke
Location: Quebec, Sherbrooke, Laval
Sponsor: Université de Sherbrooke
Sex: All
Age: 18 - 70+
Code: NCT06386510
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Montreal, New Haven CT, Oshawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia